asbestos~|~andorra~|~epileptic syndromes~|~united arab emirates~|~hypoglycemia~|~italy~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~behavior~|~androgen response element~|~any~|~any data type~|~behavior:-:point in time:^patient:-~|~explanation~|~explanation for contact lens~|~fighting~|~generalized~|~hypoglycemia, ctcae~|~are unit of measure~|~idiopathic epilepsy~|~aspects of signs~|~general symptom~|~intrathecal route of drug administration~|~manufactured sign~|~physical findings
asthma~|~lens, crystalline~|~lens diseases~|~distal (qualifier value)~|~affecting~|~asthma pathway~|~body site modifier - lower~|~involvement with~|~lower (action)~|~lower - spatial qualifier~|~only a little~|~side~|~small~|~smallest~|~entire lens~|~genus lens~|~lens (device)
brain concussion~|~confusion~|~hemorrhoids~|~disorientation~|~vomiting~|~specific qualifier value~|~multiple trauma~|~hemorrhoids, ctcae 3.0~|~hemorrhoids, ctcae 5.0~|~nr4a2 gene~|~negation~|~patient in hospital~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
tachycardia~|~caucasoid race~|~nr4a2 gene~|~negation~|~specific qualifier value~|~abdominal tenderness~|~caucasians~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~generalized abdominal pain~|~hypertensive disease~|~white color
wiskott-aldrich syndrome~|~hallucinations~|~elbow~|~nausea~|~was protein, human~|~specific qualifier value~|~bothered by nausea~|~elbow joint structure~|~entire elbow region~|~feel nausea~|~hallucinations, ctcae~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~medical product stability~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~stability determination~|~stable status~|~usual severity nausea~|~was gene~|~washoe language~|~chronic - admission level of care code~|~fine - adjective~|~generalized aches and pains~|~legal fine~|~provision of recurring care for chronic illness~|~chronic
asbestos~|~cardiac arrhythmia~|~world health organization~|~chronic obstructive airway disease~|~specific qualifier value~|~nr4a2 gene~|~negation~|~adverse event associated with cardiac arrhythmia~|~changed status~|~changing~|~fighting~|~good~|~mental status change~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~microplate well~|~not authorized~|~who temperature/humidity storage condition~|~well~|~well marginated nodule
abdominal pain~|~constipation~|~fascia~|~theses~|~constipation, ctcae~|~have constipation~|~how much distress constipation~|~how often constipation~|~unspecified~|~usual severity constipation~|~allergy severity - severe~|~borg category-ratio 10 perceived exertion score 5~|~else~|~entire fascia~|~epidermal cgvhd score 4~|~external cause codes: unspecified~|~grade 3 severe adverse event~|~in addition to~|~intensity and distress 5~|~severe (severity modifier)~|~severe - severity of illness code~|~severe - triage code~|~severe extremity pain~|~severe hallucination~|~specific qualifier value~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~abdominal pain, ctcae 5~|~abdominal rigidity~|~generalized aches and pains
muscle cramp~|~spasm~|~headache~|~nr4a2 gene~|~negation~|~skin~|~changed status~|~changing~|~entire skin~|~headache, ctcae~|~kantr gene~|~loss~|~mental status change~|~sostdc1 gene~|~sostdc1 wt allele~|~skin specimen~|~skin specimen source code~|~skin, human~|~specific qualifier value~|~widening~|~generalized aches and pains
changed status~|~changing~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~nr4a2 gene~|~negation~|~specific qualifier value
respiratory rate~|~dyspnea~|~specific qualifier value~|~all of the time~|~always (acknowledgementcondition)~|~always (frequency)~|~cdisc sdtm adverse event outcome terminology~|~count~|~count dosing unit~|~dyspnea, ctcae~|~home environment~|~house (environment)~|~nr4a2 gene~|~negation~|~out (direction)~|~removed~|~result~|~tcf23 gene~|~around~|~breaths:number = count/time:point in time:respiratory system:quantitative~|~chronic debility~|~extrinsic
fasting~|~fastk gene~|~fastk wt allele~|~fas-activated serine/threonine kinase activity~|~fasting status indicator~|~five~|~nausea and vomiting~|~rapid
membrane~|~disease~|~membrane device~|~tissue membrane~|~arid1a protein, human~|~halaven~|~arid1a wt allele~|~held - activity status~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~fever with chills
migraine disorders~|~headache~|~headache, ctcae~|~specific qualifier value~|~ounce
allergic reaction~|~allergy specialty~|~hypersensitivity~|~allergic disposition~|~allergic urticaria~|~allergy - charge type reason~|~response to antigens
italy~|~mental status change~|~nr4a2 gene~|~negation~|~specific qualifier value~|~intrathecal route of drug administration
elephants~|~brain~|~abnormal coordination~|~cerebral hemisphere structure (body structure)~|~degenerative polyarthritis~|~family elephantidae (organism)~|~fellow~|~mental status change~|~nr4a2 gene~|~negation~|~specific qualifier value
hyperventilation~|~chronic obstructive airway disease~|~dyskinetic syndrome~|~specific qualifier value~|~exacerbation acute
facial injuries~|~epileptic syndromes~|~compliance~|~andorra~|~physical examination~|~generalized~|~diagnosis~|~and~|~and - dosing instruction fragment~|~biomechanical compliance~|~compliance behavior~|~diagnosis classification - diagnosis~|~diagnosis code~|~diagnosis study~|~diagnosis:impression/interpretation of study:point in time:^patient:nominal~|~encounter~|~examination~|~facilitated oscillatory release technique~|~healthcare encounter~|~in addition to~|~medical examination~|~not otherwise specified~|~operational compliance~|~patient visit~|~preposition for~|~relationshipconjunction - and~|~report (document)~|~reported~|~reporting~|~suspected diagnosis~|~suspected qualifier~|~visit~|~wwox gene~|~wwox wt allele~|~with - dosing instruction fragment~|~diagnosis aspect~|~idiopathic epilepsy~|~general medical service~|~safety reporting documentation~|~united states military commissioned officer o10
symptoms~|~andorra~|~and~|~and - dosing instruction fragment~|~cdisc sdtm size terminology~|~emotional well-being~|~emotional state observations~|~emotional states~|~ideal~|~involvement with~|~nr4a2 gene~|~negation~|~relationshipconjunction - and~|~specific qualifier value~|~suicidal~|~symptoms aspect~|~size~|~size - solid dosage form
intestinal obstruction~|~vomiting~|~italy~|~adgre4p gene~|~accident caused by unspecified fire~|~facilitated oscillatory release technique~|~fire - disasters~|~fire - physical phenomenon~|~fire medical device problem~|~fire as a heat source~|~not asked~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~preposition for~|~specific qualifier value~|~wwox gene~|~wwox wt allele~|~acute onset pain~|~bothered by vomiting~|~comprehensive score for financial toxicity~|~cost aspects~|~financial cost~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~intrathecal route of drug administration~|~pain localized to other parts of lower abdomen~|~unspecified~|~usual severity vomiting~|~vomiting, ctcae
polyuria~|~hyperglycemia~|~science~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~nr4a2 gene~|~negation~|~specific qualifier value~|~general symptom~|~generalized abdominal pain~|~generalized aches and pains~|~left lower quadrant pain~|~right lower quadrant pain
epilepsy~|~idiopathic generalized epilepsy~|~specific qualifier value~|~nr4a2 gene~|~negation~|~unspecified injury of hip~|~generalized aches and pains
dyspnea~|~chest pain~|~chest pain on breathing~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~chest pain:finding:point in time:^patient:ordinal~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
andorra~|~neoplasm metastasis~|~and~|~and - dosing instruction fragment~|~nr4a2 gene~|~negation~|~relationshipconjunction - and~|~specific qualifier value~|~hemorrhage~|~patient in hospital~|~encounter~|~firstly~|~healthcare encounter~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~patient visit~|~rush~|~traumatic~|~visit~|~widening~|~scenario~|~generalized aches and pains~|~recurrent hemorrhage~|~secondary to~|~metastatic qualifier~|~second (number)
abdominal pain~|~hemorrhoids~|~fingers~|~hand~|~andorra~|~italy~|~allergy severity - severe~|~and~|~and - dosing instruction fragment~|~borg category-ratio 10 perceived exertion score 5~|~entire hand~|~epidermal cgvhd score 4~|~external cause codes: unspecified~|~fingers, unit of measurement~|~first (number)~|~firstly~|~grade 3 severe adverse event~|~hemorrhoids, ctcae 3.0~|~hemorrhoids, ctcae 5.0~|~in addition to~|~intensity and distress 5~|~nr4a2 gene~|~negation~|~relationshipconjunction - and~|~severe (severity modifier)~|~severe - severity of illness code~|~severe - triage code~|~severe extremity pain~|~severe hallucination~|~specific qualifier value~|~traumatic injury~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~hand - unit of measure~|~trauma to the abdomen~|~abdominal pain, ctcae 5~|~abdominal rigidity~|~generalized aches and pains~|~intrathecal route of drug administration
wiskott-aldrich syndrome~|~acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~pneumonia~|~sepsis~|~mental orientation~|~bcr protein, human~|~septicemia~|~theses~|~was protein, human~|~fever~|~andorra~|~chills~|~organism~|~unspecified~|~science~|~genotype~|~all~|~and~|~and - dosing instruction fragment~|~bcr gene~|~bcr wt allele~|~cdisc adas-cog - orientation summary score~|~chills, ctcae~|~genomic orientation~|~montreal cognitive assessment orientation test~|~orientation (spatial)~|~relationshipconjunction - and~|~sepsis (invertebrate)~|~sepsis, ctcae~|~universal restriction modifier (core metadata concept)~|~was gene~|~washoe language~|~with intensity~|~all - localmarkupignore~|~all - tablerules~|~fever symptoms (finding)~|~fever, ctcae
craniocerebral trauma~|~face~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~elovl6 gene~|~entire face~|~external cause codes: unspecified~|~fance wt allele~|~fanconi anemia, complementation group e~|~face (spatial concept)~|~much~|~nr4a2 gene~|~negation~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~unspecified injury of ankle
wiskott-aldrich syndrome~|~nurse administrator~|~diazooxonorleucine~|~tachycardia~|~chest pain~|~was protein, human~|~fever~|~chills~|~to specify~|~chest pain:finding:point in time:^patient:ordinal~|~chills, ctcae~|~external cause codes: unspecified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~was gene~|~washoe language~|~fever symptoms (finding)~|~fever, ctcae
urinary tract infection~|~infection by site~|~nr4a2 gene~|~negation~|~not otherwise specified~|~recurrent urinary tract infection~|~sostdc1 gene~|~sostdc1 wt allele~|~undifferentiated sex~|~unspecified~|~unspecified method of administration~|~urinary tract infection, ctcae
pain~|~dizziness~|~lightheadedness~|~trestolone~|~c1orf56 gene~|~early complication of trauma~|~encounter~|~firstly~|~half~|~healthcare encounter~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~nr4a2 gene~|~negation~|~patient visit~|~specific qualifier value~|~tension~|~ultra-violet~|~visit~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~generalized aches and pains~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain~|~atherosclerotic
specific qualifier value~|~traumatic and/or non-traumatic injury~|~traumatic injury
muscle weakness~|~nurse administrator~|~diazooxonorleucine~|~paresis~|~cardiac arrhythmia~|~nausea~|~adverse event associated with cardiac arrhythmia~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~to specify~|~usual severity nausea~|~weakness~|~chronic debility
communicable diseases~|~fascia~|~brain~|~adverse event associated with infection~|~cerebral hemisphere structure (body structure)~|~entire fascia~|~infection
tremor~|~hypertensive disease~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~tremor, ctcae 3.0~|~tremor, ctcae 5.0~|~chronic debility
wiskott-aldrich syndrome~|~was protein, human~|~fever~|~chills~|~somnolence~|~was gene~|~washoe language~|~chills, ctcae~|~drowsiness~|~drowsiness visual analogue scale~|~good~|~mental status change~|~microplate well~|~nr4a2 gene~|~negation~|~specific qualifier value~|~well~|~well marginated nodule~|~fever symptoms (finding)~|~fever with chills~|~fever, ctcae
chest pain~|~chest pain:finding:point in time:^patient:ordinal
headache~|~headache, ctcae
abdominal pain~|~vomiting~|~allergy severity - severe~|~borg category-ratio 10 perceived exertion score 5~|~epidermal cgvhd score 4~|~grade 3 severe adverse event~|~hematocrit level~|~hematocrit procedure~|~in addition to~|~intensity and distress 5~|~severe (severity modifier)~|~severe - severity of illness code~|~severe - triage code~|~severe extremity pain~|~severe hallucination~|~with - dosing instruction fragment~|~abdominal pain, ctcae 5~|~abdominal rigidity~|~bothered by vomiting~|~generalized abdominal pain~|~generalized aches and pains~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
italy~|~nr4a2 gene~|~negation~|~specific qualifier value~|~intrathecal route of drug administration~|~pain in limb, lower leg
seizures~|~craniocerebral trauma~|~united arab emirates~|~foot~|~specific qualifier value~|~andorra~|~mass of body structure~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~and~|~and - dosing instruction fragment~|~androgen response element~|~fbn1 gene~|~fbn1 wt allele~|~feet, unit of measurement~|~mass of body region~|~mass, a measure of quantity of matter~|~molecular mass~|~morphology, attenuation, size, and structure criteria~|~relationshipconjunction - and~|~specimen source codes - mass~|~are unit of measure~|~have swelling
andorra~|~and~|~and - dosing instruction fragment~|~body site modifier - lower~|~lower (action)~|~lower - spatial qualifier~|~quadrant~|~relationshipconjunction - and~|~generalized abdominal pain~|~generalized aches and pains~|~left~|~left sided~|~table cell horizontal align - left~|~nausea or abdominal pain
back pain~|~fingers~|~andorra~|~wrist injuries~|~nr4a2 gene~|~negation~|~patient in hospital~|~specific qualifier value~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~neck injuries~|~and~|~and - dosing instruction fragment~|~catch - finding of sensory dimension of pain~|~fingers, unit of measurement~|~relationshipconjunction - and~|~hand and wrist
nurse administrator~|~abdominal pain~|~constipation~|~diazooxonorleucine~|~dyspnea~|~constipation, ctcae~|~have constipation~|~how much distress constipation~|~how often constipation~|~usual severity constipation~|~dyspnea, ctcae~|~in addition to~|~specific qualifier value~|~to specify~|~with - dosing instruction fragment~|~abdominal pain, ctcae 5~|~abdominal rigidity~|~generalized abdominal pain~|~generalized aches and pains~|~severe pain
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~andorra~|~poisoning~|~bcr protein, human~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~science~|~all~|~bcr gene~|~bcr wt allele~|~biological factors~|~external cause codes: unspecified~|~feeling suicidal (finding)~|~geographic state~|~indeterminate~|~state~|~state ownership~|~stress~|~stress bismuth subsalicylate~|~us state~|~undetermined~|~undetermined finding~|~universal restriction modifier (core metadata concept)~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~w stress~|~all - localmarkupignore~|~all - tablerules~|~emotional shock~|~general symptom
unconscious state~|~nr4a2 gene~|~negation~|~specific qualifier value
nurse administrator~|~diazooxonorleucine~|~dyspnea~|~ischemia~|~caucasoid race~|~forearm injuries~|~ischemia procedure~|~nr4a2 gene~|~negation~|~specific qualifier value~|~dyspnea, ctcae~|~to specify~|~caucasians~|~white color
heroin~|~syncope~|~dyspnea~|~dizziness~|~ability~|~lightheadedness~|~andorra~|~disease~|~shock~|~membrane~|~able (finding)~|~and~|~and - dosing instruction fragment~|~collapse (finding)~|~collapse (morphologic abnormality)~|~collapse of device~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~hypertension, ctcae~|~hypertensive disease~|~membrane device~|~relationshipconjunction - and~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~syncope (amphibian)~|~syncope, ctcae 5.0~|~tissue membrane~|~usual severity shortness of breath~|~unspecified
apnea~|~apnea, ctcae~|~nr4a2 gene~|~negation~|~specific qualifier value
brain diseases~|~disease~|~membrane~|~membrane device~|~not otherwise specified~|~stenia~|~tissue membrane~|~bothered by night sweats~|~elderly (population group)~|~main~|~night sweats~|~old age~|~primary
foot~|~feet, unit of measurement~|~home environment~|~house (environment)~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~sostdc1 gene~|~sostdc1 wt allele~|~specific qualifier value
wiskott-aldrich syndrome~|~nurse administrator~|~abdominal pain~|~diazooxonorleucine~|~nausea~|~was protein, human~|~vomiting~|~abdomen~|~signs and symptoms~|~allergy severity - severe~|~borg category-ratio 10 perceived exertion score 5~|~bothered by nausea~|~epidermal cgvhd score 4~|~feel nausea~|~grade 3 severe adverse event~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~in addition to~|~intensity and distress 5~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~severe (severity modifier)~|~severe - severity of illness code~|~severe - triage code~|~severe extremity pain~|~severe hallucination~|~to specify~|~usual severity nausea~|~was gene~|~washoe language~|~with - dosing instruction fragment~|~abdominal (qualifier value)~|~abdominal pain, ctcae 5~|~abdominal tenderness~|~bothered by vomiting~|~general symptom~|~generalized aches and pains~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
tachycardia~|~cardiac arrhythmia~|~comment~|~andorra~|~anxiety~|~specific qualifier value~|~anxiety disorders~|~adverse event associated with cardiac arrhythmia~|~and~|~and - dosing instruction fragment~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~biological factors~|~comment domain~|~determined by~|~else~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~published comment~|~relationshipconjunction - and~|~sostdc1 gene~|~sostdc1 wt allele~|~meaning
syncope~|~alcohol consumption~|~specific qualifier value~|~changed status~|~changing~|~external cause codes: unspecified~|~intoxication~|~mental status change~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~not authorized~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~atherosclerotic
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~nurse administrator~|~pain~|~diazooxonorleucine~|~fingers~|~bcr protein, human~|~andorra~|~face~|~wrist injuries~|~italy~|~multiple trauma~|~all~|~and~|~and - dosing instruction fragment~|~bcr gene~|~bcr wt allele~|~elovl6 gene~|~entire face~|~fance wt allele~|~fanconi anemia, complementation group e~|~face (spatial concept)~|~fingers, unit of measurement~|~nr4a2 gene~|~negation~|~relationshipconjunction - and~|~specific qualifier value~|~to specify~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~universal restriction modifier (core metadata concept)~|~all - localmarkupignore~|~all - tablerules~|~hand and wrist~|~abnormally high~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~high~|~high (finding)~|~high level~|~high mitosis-karyorrhexis index~|~how much distress pain~|~ipss risk category high~|~ipss-r risk category high~|~intrathecal route of drug administration~|~message waiting priority - high~|~observation value - high~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain~|~value above reference range~|~high - actexposurelevelcode
wiskott-aldrich syndrome~|~acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~was protein, human~|~diabetes mellitus~|~bcr protein, human~|~hyperglycemia~|~hypoglycemia~|~nausea~|~vomiting~|~specific qualifier value~|~was gene~|~washoe language~|~all~|~bcr gene~|~bcr wt allele~|~bothered by nausea~|~diabetes~|~emotional tenderness~|~feel nausea~|~glucose in blood specimen above reference range~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~hyperglycemia, ctcae~|~hypoglycemia, ctcae~|~main~|~nr4a2 gene~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~negation~|~patient in hospital~|~sore to touch~|~this (eukaryote)~|~universal restriction modifier (core metadata concept)~|~usual severity nausea~|~all - localmarkupignore~|~all - tablerules~|~bothered by vomiting~|~fine - adjective~|~generalized aches and pains~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~legal fine~|~usual severity vomiting~|~vomiting, ctcae
migraine disorders~|~headache~|~united arab emirates~|~nausea~|~negative surgical margin~|~brain~|~androgen response element~|~bothered by nausea~|~cerebral hemisphere structure (body structure)~|~clear~|~epidermal cgvhd score 0~|~feel nausea~|~have nausea~|~headache, ctcae~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~remote control command - clear~|~usual severity nausea~|~are unit of measure~|~primary~|~primary operation~|~sound - physical agent~|~true primary (qualifier value)~|~unspecified
angina pectoris~|~chest pain~|~vomiting~|~external cause codes: unspecified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~bothered by vomiting~|~chest pain:finding:point in time:^patient:ordinal~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
artificial cardiac pacemaker~|~sinoatrial node~|~anxiety~|~italy~|~anxiety disorders~|~president brand of dental material~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~nr4a2 gene~|~negation~|~specific qualifier value~|~intrathecal route of drug administration
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~back pain~|~bcr protein, human~|~italy~|~generalized abdominal pain~|~signs and symptoms~|~all~|~bcr gene~|~bcr wt allele~|~cough frequency~|~cough, ctcae~|~coughing~|~have been coughing~|~how much distress cough~|~nr4a2 gene~|~negation~|~specific qualifier value~|~universal restriction modifier (core metadata concept)~|~usual severity cough~|~all - localmarkupignore~|~all - tablerules~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~general symptom~|~generalized aches and pains~|~intrathecal route of drug administration
colitis~|~edema~|~colitis, ctcae~|~edema:finding:point in time:^patient:ordinal~|~mental status change~|~nr4a2 gene~|~negation~|~sostdc1 gene~|~sostdc1 wt allele~|~specific qualifier value
nausea~|~vomiting~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~usual severity nausea~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
syncope~|~tachycardia~|~cardiac arrhythmia~|~adverse event associated with cardiac arrhythmia
wiskott-aldrich syndrome~|~asthma~|~dyspnea~|~was protein, human~|~asthma pathway~|~change -- procedure~|~changed status~|~changing~|~delta (difference)~|~dyspnea, ctcae~|~exacerbation~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~nr4a2 gene~|~nearly~|~negation~|~patient in hospital~|~specific qualifier value~|~sphincter~|~toxic effect of unspecified substance~|~was gene~|~washoe language
nurse administrator~|~diazooxonorleucine~|~andorra~|~hypotension~|~specific qualifier value~|~and~|~and - dosing instruction fragment~|~biological factors~|~butting~|~else~|~good~|~hypotension, ctcae~|~indeterminate~|~mental status change~|~microplate well~|~nr4a2 gene~|~negation~|~poison ivy antigen~|~relationshipconjunction - and~|~suicide attempt incident code~|~suicide attempt, ctcae~|~suicide attempt~|~to specify~|~toxicodendron radicans~|~undetermined~|~undetermined finding~|~well~|~well marginated nodule~|~jokes
chest pain~|~hypertensive disease~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~chest pain:finding:point in time:^patient:ordinal
wiskott-aldrich syndrome~|~abdominal pain~|~chest pain~|~was protein, human~|~generalized aches and pains~|~allergy severity - severe~|~borg category-ratio 10 perceived exertion score 5~|~chest and abdomen~|~epidermal cgvhd score 4~|~grade 3 severe adverse event~|~intensity and distress 5~|~nr4a2 gene~|~negation~|~patient in hospital~|~severe (severity modifier)~|~severe - severity of illness code~|~severe - triage code~|~severe extremity pain~|~severe hallucination~|~specific qualifier value~|~was gene~|~washoe language~|~abdominal pain, ctcae 5~|~abdominal rigidity~|~chest pain:finding:point in time:^patient:ordinal~|~generalized abdominal pain~|~upper abdominal pain
wiskott-aldrich syndrome~|~was protein, human~|~sepsis~|~classification~|~septicemia~|~chronic obstructive airway disease~|~fever~|~andorra~|~chills~|~was gene~|~washoe language~|~acute - triage code~|~acute bronchitis~|~admission level of care code - acute~|~and~|~and - dosing instruction fragment~|~chills, ctcae~|~lower respiratory tract infection~|~relationshipconjunction - and~|~sepsis (invertebrate)~|~sepsis, ctcae~|~acute~|~acute inpatient encounter~|~fever symptoms (finding)~|~fever, ctcae
wiskott-aldrich syndrome~|~hospice care~|~communicable diseases~|~diabetes mellitus~|~facial paresis~|~hyperglycemia~|~was protein, human~|~brain~|~specific qualifier value~|~abnormal coordination~|~adverse event associated with infection~|~cerebral hemisphere structure (body structure)~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~infection~|~was gene~|~washoe language~|~hospice environment~|~non mouse~|~negation
cutaneous fistula~|~sepsis~|~nervousness~|~septicemia~|~feeling nervous~|~nasal sinus~|~organized~|~senior - suffix~|~sepsis (invertebrate)~|~sepsis, ctcae~|~sinus - general anatomical term~|~specific qualifier value~|~pathologic fistula
dyspnea~|~asthma~|~nurse administrator~|~pneumonia~|~diazooxonorleucine~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~to specify~|~usual severity shortness of breath~|~asthma pathway~|~in addition to~|~organism~|~with - dosing instruction fragment~|~exacerbation acute
injury of elbow~|~injury of thigh~|~nonspecific~|~specific qualifier value~|~traumatic injury~|~unspecified injury of thigh
paracentesis~|~foot~|~conduct disorder~|~specific qualifier value~|~feet, unit of measurement~|~mental status change~|~nr4a2 gene~|~negation~|~not authorized~|~sostdc1 gene~|~sostdc1 wt allele~|~singular~|~widening~|~aggressive behavior~|~aggressive course~|~entity risk - aggressive~|~flnb gene~|~nxf1 gene~|~precaution code - aggressive~|~risk codes - aggressive~|~sec14l2 gene~|~tracheal antimicrobial peptide~|~uso1 gene
chronic obstructive airway disease~|~breath~|~existential restriction modifier (core metadata concept)~|~nr4a2 gene~|~negation~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~show~|~some (qualifier value)~|~specific qualifier value~|~five
dyspnea~|~aranesp~|~chronic obstructive airway disease~|~ischemia~|~italy~|~dyspnea, ctcae~|~ischemia procedure~|~nr4a2 gene~|~negation~|~specific qualifier value~|~worried~|~exacerbation acute~|~five~|~intrathecal route of drug administration
asthma~|~dyspnea~|~disease~|~membrane~|~haldol~|~wheezing~|~membrane device~|~tissue membrane~|~trachea~|~tracheal diseases~|~asthma pathway~|~causing~|~entire trachea~|~fixation - action~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~physical object~|~psychological fixation~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~trachea (moth)~|~usual severity shortness of breath~|~exacerbation acute~|~sample fixation~|~elderly (population group)~|~old age~|~wheezing, ctcae
anxiety~|~italy~|~anxiety disorders~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~nr4a2 gene~|~negation~|~specific qualifier value~|~intrathecal route of drug administration
wiskott-aldrich syndrome~|~was protein, human~|~diarrhea~|~fever~|~chills~|~was gene~|~washoe language~|~chills, ctcae~|~diarrhea, ctcae~|~external cause codes: unspecified~|~have diarrhea~|~how much distress diarrhea~|~how often diarrhea~|~nr4a2 gene~|~negation~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity diarrhea~|~fever symptoms (finding)~|~fever with chills~|~fever, ctcae
transient ischemic attack~|~communicable diseases~|~brain~|~diagnosis~|~adverse event associated with infection~|~cerebral hemisphere structure (body structure)~|~diagnosis classification - diagnosis~|~diagnosis code~|~diagnosis study~|~diagnosis:impression/interpretation of study:point in time:^patient:nominal~|~experimental result~|~infection~|~mental status change~|~nr4a2 gene~|~negation~|~result~|~specific qualifier value~|~what subject filter - result~|~diagnosis aspect~|~hypertensive disease~|~increase in blood pressure~|~reading (activity)~|~reading (datum presentation)~|~reading ability question~|~transient hypertension
wiskott-aldrich syndrome~|~nurse administrator~|~diazooxonorleucine~|~craniocerebral trauma~|~alcohol consumption~|~was protein, human~|~to specify~|~andorra~|~and~|~and - dosing instruction fragment~|~biological factors~|~poison ivy antigen~|~relationshipconjunction - and~|~toxicodendron radicans~|~was gene~|~washoe language~|~determined by
headache~|~face~|~italy~|~headache, ctcae~|~nr4a2 gene~|~negation~|~specific qualifier value~|~diagnosis~|~chief complaint (finding)~|~elovl6 gene~|~encounter~|~entire face~|~explanation~|~explanation for contact lens~|~fance wt allele~|~fanconi anemia, complementation group e~|~face (spatial concept)~|~facilitated oscillatory release technique~|~healthcare encounter~|~patient visit~|~preposition for~|~report (document)~|~reported~|~reporting~|~suspected diagnosis~|~suspected qualifier~|~visit~|~wwox gene~|~wwox wt allele~|~without~|~general medical service~|~generalized~|~generalized aches and pains~|~intrathecal route of drug administration~|~safety reporting documentation~|~united states military commissioned officer o10
wiskott-aldrich syndrome~|~arid1a protein, human~|~was protein, human~|~andorra~|~brain diseases~|~chills~|~science~|~arid1a wt allele~|~and~|~and - dosing instruction fragment~|~chills, ctcae~|~cough with fever~|~held - activity status~|~relationshipconjunction - and~|~was gene~|~washoe language~|~general symptom~|~main~|~primary
seizures~|~idiopathic generalized epilepsy~|~fecal immunochemical test~|~fit (action)~|~fit and well~|~nr4a2 gene~|~negation~|~prosthesis fit~|~specific qualifier value~|~widening
chronic obstructive airway disease
hematemesis~|~vomiting~|~andorra~|~ulcer~|~nr4a2 gene~|~negation~|~specific qualifier value~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae~|~heart~|~and~|~and - dosing instruction fragment~|~entire heart~|~intestinal hemorrhage nos~|~patient in hospital~|~relationshipconjunction - and~|~rush~|~unresponsive to treatment~|~widening~|~unresponsive behavior~|~five~|~lower gastrointestinal hemorrhage
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~pain~|~andorra~|~ask protein, human~|~bcr protein, human~|~nausea~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~anxiety~|~disease~|~pelvis~|~anxiety disorders~|~activities scale for kids~|~all~|~anaplastic sarcoma of the kidney~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~bcr gene~|~bcr wt allele~|~bothered by nausea~|~cdisc sdtm size terminology~|~dbf4 gene~|~dbf4 wt allele~|~feel nausea~|~geographic state~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~psychoactive substance~|~restlessness and agitation~|~specific qualifier value~|~state~|~state ownership~|~stress~|~stress bismuth subsalicylate~|~us state~|~universal restriction modifier (core metadata concept)~|~usual severity nausea~|~w stress~|~all - localmarkupignore~|~all - tablerules~|~emotional shock~|~size~|~size - solid dosage form~|~administration method - pain~|~adverse event associated with pain~|~definitely related to intervention~|~extrinsic~|~feel pain~|~frequency of pain question~|~general symptom~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~relate - vinyl resin~|~related personal status~|~relationships~|~role link type - related~|~usual severity pain
dizziness~|~alcohol abuse~|~lightheadedness~|~behavior showing increased motor activity~|~alcohol abuse scale (basc-2)~|~overactivity~|~uncomplicated~|~worried
cocaine~|~andorra~|~ability~|~symptoms~|~anger~|~and~|~and - dosing instruction fragment~|~determined by~|~poison ivy antigen~|~relationshipconjunction - and~|~toxicodendron radicans~|~science~|~channel~|~channel object~|~cocaine measurement~|~restlessness and agitation~|~symptoms aspect~|~bearing device
facial injuries~|~falls~|~italy~|~falling injury~|~generalized~|~nr4a2 gene~|~negation~|~specific qualifier value~|~tendency to fall~|~intrathecal route of drug administration
wiskott-aldrich syndrome~|~was protein, human~|~fever~|~chills~|~chills, ctcae~|~was gene~|~washoe language~|~fever symptoms (finding)~|~fever, ctcae
syncope~|~wiskott-aldrich syndrome~|~chest pain~|~nausea~|~was protein, human~|~vomiting~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~specific qualifier value~|~usual severity nausea~|~was gene~|~washoe language~|~bothered by vomiting~|~chest pain:finding:point in time:^patient:ordinal~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
hypoglycemia~|~hypoxemia~|~italy~|~fighting~|~hypoglycemia, ctcae~|~mental status change~|~nr4a2 gene~|~negation~|~specific qualifier value~|~intrathecal route of drug administration
pain~|~chest pain~|~encounter~|~firstly~|~healthcare encounter~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~patient visit~|~traumatic injury~|~visit~|~acute pain due to trauma~|~administration method - pain~|~adverse event associated with pain~|~chest pain:finding:point in time:^patient:ordinal~|~entire right shoulder region~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~structure of right shoulder region~|~usual severity pain
nausea~|~neck injuries~|~bothered by nausea~|~encounter~|~facilitated oscillatory release technique~|~feel nausea~|~firstly~|~have nausea~|~healthcare encounter~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~patient visit~|~preposition for~|~usual severity nausea~|~visit~|~wwox gene~|~wwox wt allele~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease~|~secondary hypertension
muscle cramp~|~spasm~|~ischemia~|~ischemia procedure~|~nr4a2 gene~|~negation~|~widening~|~skin~|~climbing~|~does climb~|~entire skin~|~kantr gene~|~skin specimen~|~skin specimen source code~|~skin, human~|~specific qualifier value
chest pain~|~armenia~|~acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~muscle spasticity~|~nurse administrator~|~pain~|~back pain~|~diazooxonorleucine~|~bcr protein, human~|~spastic~|~upper arm~|~to specify~|~chest pain:finding:point in time:^patient:ordinal~|~upper extremity~|~nr4a2 gene~|~negation~|~sostdc1 gene~|~sostdc1 wt allele~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~akr1a1 wt allele~|~aldose reductase m gene~|~armc9 gene~|~all~|~axillary reverse mapping~|~bcr gene~|~bcr wt allele~|~entire upper arm~|~entire upper limb~|~protocol treatment arm~|~sequence arm~|~specific qualifier value~|~universal restriction modifier (core metadata concept)~|~all - localmarkupignore~|~all - tablerules~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~five~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
chest pain~|~nurse administrator~|~diazooxonorleucine~|~chest pain:finding:point in time:^patient:ordinal~|~acute myocardial infarction~|~nr4a2 gene~|~negation~|~specific qualifier value~|~widening~|~specify other
chest pain~|~chest pain:finding:point in time:^patient:ordinal~|~specific qualifier value~|~nausea and vomiting
andorra~|~cardiac arrhythmia~|~abdomen~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~skin~|~adverse event associated with cardiac arrhythmia~|~emotional tenderness~|~fbn1 gene~|~fbn1 wt allele~|~fibrillation~|~mass of body region~|~mass of body structure~|~mass of skin~|~mass, a measure of quantity of matter~|~molecular mass~|~morphology, attenuation, size, and structure criteria~|~nr4a2 gene~|~negation~|~patient in hospital~|~sore to touch~|~specific qualifier value~|~specimen source codes - mass~|~unspecified atrial fibrillation~|~abdominal (qualifier value)~|~generalized abdominal pain~|~localized pain~|~localized swelling
syncope~|~allergic reaction~|~allergy specialty~|~genetic carriers~|~vomiting~|~specific qualifier value~|~hypersensitivity~|~allergic disposition~|~allergy - charge type reason~|~carrier device~|~carrier of disorder~|~else~|~external cause codes: unspecified~|~mental status change~|~nr4a2 gene~|~negation~|~reprint carrier~|~response to antigens~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~small-molecule carrier or transporter~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
italy~|~disease~|~psychotic disorders~|~fatigue~|~nr4a2 gene~|~negation~|~specific qualifier value~|~intrathecal route of drug administration~|~condition~|~condition domain~|~condition:find:pt:^patient:nom~|~logical condition~|~mental disorders~|~physiological~|~strange and inexplicable behavior~|~substance~|~fatigue subordinate domain~|~fatigue, ctcae 5.0~|~feel fatigue